Cancer Spit Test Device Market – Non-Invasive Early Detection...

ha aggiunto una foto Altre informazioni

2026-01-28 10:16:21 -

Cancer Spit Test Device Market – Non-Invasive Early Detection Technology, Liquid Biopsy Innovation & Diagnostic Accessibility

Executive Summary The Cancer Spit Test Device Market is at the forefront of the diagnostic revolution, shifting oncology from invasive biopsies toward non-invasive liquid biopsies. These devices analyze saliva for biomarkers such as circulating tumor DNA (ctDNA), RNA, and proteins, offering a painless and repeatable method for early cancer screening. The market is primarily driven by...

0 Commenti 0 condivisioni 810 Views 0 Anteprima